Compare Coupang Inc (CPNG) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Coupang Inc vs Enveric Biosciences Inc — how do they compare? Coupang Inc trades at $16.5 (market cap $29.66B), while Enveric Biosciences Inc trades at $1.59 (market cap $6.20M). The key difference: Coupang Inc is far larger — about 4783.9× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| CPNG | ENVB | |
|---|---|---|
Market Cap | $29.66B | $6.20M |
Sector | Consumer Cyclical | Health |
52-Week High | $33.53 | $17.40 |
52-Week Low | $15.12 | $1.27 |
Enterprise Value | $29.18B | $1.30M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CPNG trades at $16.55, up 2.22% today, with a neutral technical signal and bearish moving averages. Revenue grew to $34.53B in 2025, but recent quarters missed EPS expectations, and 2026 projects a net loss. The stock is undervalued relative to analyst consensus targets near $23.38, supported by strong cash flow from operations of $1.77B in 2025.
Outlook remains mixed due to near-term profitability challenges, but long-term growth in South Korean e-commerce and expansion into Taiwan offer upside. Risks include competitive pressures, regulatory fines, and execution on margin improvement. Analyst sentiment is overwhelmingly bullish with 87.5% buy ratings.
ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.
Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Coupang Inc
Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
